Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tilman M Hackeng

Showing results (101-110 of 141) with videos related to

Pageof 15
Sort By:
Journal of Thrombosis and Haemostasis : JTH|October 22, 2023
In vitro and ex vivo rescue of a nonsense mutation responsible for severe coagulation factor V deficiencyAlice M Todaro, Claudia M Radu, Maria Ciccone, et al.
Bioconjugate Chemistry|February 21, 2020
Tick Saliva Protein Evasin-3 Allows for Visualization of Inflammation in Arteries through Interactions with CXC-Type Chemokines Deposited on Activated EndotheliumStepan S Denisov, Alexandra C A Heinzmann, Tanja Vajen, et al.
Thrombosis and Haemostasis|February 17, 2018
Suppressive Role of Tissue Factor Pathway Inhibitor-α in Platelet-Dependent Fibrin Formation under Flow Is Restricted to Low Procoagulant StrengthStella Thomassen, Tom G Mastenbroek, Frauke Swieringa, et al.
Scientific Reports|July 15, 2018
Blocking CCL5-CXCL4 heteromerization preserves heart function after myocardial infarction by attenuating leukocyte recruitment and NETosisTanja Vajen, Rory R Koenen, Isabella Werner, et al.
Journal of Cellular and Molecular Medicine|February 12, 2014
Controlled intramyocardial release of engineered chemokines by biodegradable hydrogels as a treatment approach of myocardial infarctionDelia Projahn, Sakine Simsekyilmaz, Smriti Singh, et al.
Nature Communications|May 23, 2022
Extracellular vimentin mimics VEGF and is a target for anti-angiogenic immunotherapyJudy R van Beijnum, Elisabeth J M Huijbers, Karlijn van Loon, et al.
American Journal of Respiratory and Critical Care Medicine|January 17, 2012
Disruption of platelet-derived chemokine heteromers prevents neutrophil extravasation in acute lung injuryJochen Grommes, Jean-Eric Alard, Maik Drechsler, et al.
Journal of Thrombosis and Haemostasis : JTH|April 21, 2022
Antithrombotic potential of a single-domain antibody enhancing the activated protein C-cofactor activity of protein SJosepha C Sedzro, Frédéric Adam, Claire Auditeau, et al.
Blood|April 11, 2020
Platelet protein S limits venous but not arterial thrombosis propensity by controlling coagulation in the thrombusSara Calzavarini, Raja Prince-Eladnani, François Saller, et al.
Journal of Thrombosis and Haemostasis : JTH|February 19, 2021
Severe thrombophilia in a factor V-deficient patient homozygous for the Ala2086Asp mutation (FV Besançon)Elisabetta Castoldi, Nathalie Hézard, Guillaume Mourey, et al.
Pageof 15

Showing results (101-110 of 141) with videos related to

Sort By:
Pageof 15
Journal of Thrombosis and Haemostasis : JTH|October 22, 2023
In vitro and ex vivo rescue of a nonsense mutation responsible for severe coagulation factor V deficiencyAlice M Todaro, Claudia M Radu, Maria Ciccone, et al.
Bioconjugate Chemistry|February 21, 2020
Tick Saliva Protein Evasin-3 Allows for Visualization of Inflammation in Arteries through Interactions with CXC-Type Chemokines Deposited on Activated EndotheliumStepan S Denisov, Alexandra C A Heinzmann, Tanja Vajen, et al.
Thrombosis and Haemostasis|February 17, 2018
Suppressive Role of Tissue Factor Pathway Inhibitor-α in Platelet-Dependent Fibrin Formation under Flow Is Restricted to Low Procoagulant StrengthStella Thomassen, Tom G Mastenbroek, Frauke Swieringa, et al.
Scientific Reports|July 15, 2018
Blocking CCL5-CXCL4 heteromerization preserves heart function after myocardial infarction by attenuating leukocyte recruitment and NETosisTanja Vajen, Rory R Koenen, Isabella Werner, et al.
Journal of Cellular and Molecular Medicine|February 12, 2014
Controlled intramyocardial release of engineered chemokines by biodegradable hydrogels as a treatment approach of myocardial infarctionDelia Projahn, Sakine Simsekyilmaz, Smriti Singh, et al.
Nature Communications|May 23, 2022
Extracellular vimentin mimics VEGF and is a target for anti-angiogenic immunotherapyJudy R van Beijnum, Elisabeth J M Huijbers, Karlijn van Loon, et al.
American Journal of Respiratory and Critical Care Medicine|January 17, 2012
Disruption of platelet-derived chemokine heteromers prevents neutrophil extravasation in acute lung injuryJochen Grommes, Jean-Eric Alard, Maik Drechsler, et al.
Journal of Thrombosis and Haemostasis : JTH|April 21, 2022
Antithrombotic potential of a single-domain antibody enhancing the activated protein C-cofactor activity of protein SJosepha C Sedzro, Frédéric Adam, Claire Auditeau, et al.
Blood|April 11, 2020
Platelet protein S limits venous but not arterial thrombosis propensity by controlling coagulation in the thrombusSara Calzavarini, Raja Prince-Eladnani, François Saller, et al.
Journal of Thrombosis and Haemostasis : JTH|February 19, 2021
Severe thrombophilia in a factor V-deficient patient homozygous for the Ala2086Asp mutation (FV Besançon)Elisabetta Castoldi, Nathalie Hézard, Guillaume Mourey, et al.
Pageof 15